ScienceScienceDaily
FDA-approved epilepsy drug may help reverse osteoarthritis damage
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
How does this story make you feel?
Public sentiment
0 reactions
Too early to tell
A mood appears once a few readers have reacted.
